Katarina Zeder,Gabor Kovacs
Katarina Zeder
Madia Ampey,Daniel Steinberger,David Perlman
Madia Ampey
Purpose of review: Sarcoidosis remains a challenging disease to diagnose and treat, with a lack of reliable biomarkers to aid in diagnosis and prognosis. Advanced imaging techniques have potential to provide prognostic in...
Florence Jeny,Sophie Brun,Stéphane Tran Ba et al.
Florence Jeny et al.
Purpose of review: This review addresses the intersection between chronic pulmonary aspergillosis (CPA) and sarcoidosis, a clinically important but relatively understudied association. While few new sarcoidosis-specific d...
Pragmatic approaches to improve the care of patients with sarcoidosis [0.03%]
务实的方法来改善 sarcoidosis 患者的护理
Elliott D Crouser,John Odackal,Marjolein Drent
Elliott D Crouser
Purpose of review: Sarcoidosis is associated with an increasing global burden, driven by rising prevalence, severe organ involvement, treatment-related morbidity, and substantial impairment in quality of life (QoL). Despi...
Mark B Mallozzi,Lisa A Maier,Nancy W Lin
Mark B Mallozzi
Purpose of review: Sarcoidosis is a heterogeneous disease with unknown etiology. The role of exposures in sarcoidosis is incompletely understood. Gene-environment interactions are likely an important aspect of sarcoidosis...
James Tadjkarimi,Evelyn Lynn,Sujal Desai et al.
James Tadjkarimi et al.
Purpose of review: This review describes recent developments in the phenotyping, monitoring, and treatment of advanced pulmonary sarcoidosis (APS), highlighting the positive strides made to recognise and treat this severe...
Nonsteroid treatment options in (pulmonary) sarcoidosis. When to consider and why? [0.03%]
非甾体治疗在肺泡肉芽肿病中的应用。何时考虑及原因？
Paolo Spagnolo,Jelle Miedema
Paolo Spagnolo
Purpose of review: Sarcoidosis requires treatment in 30-50% of cases. According to current guidelines, corticosteroids (CS) are the initial drugs of choice, particularly for patients with major organ involvement or when r...
Ana Pericao,Rakesh Sharma
Ana Pericao
Purpose of review: Cardiac sarcoidosis (CS) is associated with significant morbidity and mortality, yet its diagnosis remains challenging due to heterogeneous clinical presentations and patchy myocardial involvement. Alth...
Esther J Nossent,Anton Vonk Noordegraaf
Esther J Nossent
Purpose of review: The diffusion capacity of the lungs for carbon monoxide (DLCO) is increasingly recognized as important diagnostic and prognostic marker in pulmonary hypertension. The review summarizes this diagnostic r...
Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence [0.03%]
向间质性肺病的精准影像迈进：定量影像和人工智能的应用进展
Cristina Marrocchio,Michele Ligorio,Nicola Sverzellati
Cristina Marrocchio
Purpose of review: To discuss the most recent developments in quantitative imaging and artificial intelligence (AI) applications in interstitial lung diseases (ILD). ...